Related Experiment Video
Updated: May 9, 2025
06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
104
[How many MRI sequences are required for prostate cancer detection?]
Fabian Falkenbach1,2, Tim Inderhees1, Lars Budäus1,3
1Martini-Klinik Prostatakarzinomzentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Aktuelle Urologie
|May 5, 2025
Summary
Biparametric MRI (bpMRI), without contrast enhancement, is recommended for early prostate cancer detection due to similar efficacy and reduced costs compared to multiparametric MRI (mpMRI). Dynamic Contrast-Enhanced (DCE) MRI may be reserved for specific complex cases.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Multiparametric MRI (mpMRI) combines anatomical, diffusion-weighted (DWI), and contrast-enhanced (DCE) sequences for prostate cancer assessment.
- DWI assesses water molecule movement for tissue composition, while DCE evaluates perfusion and angiogenesis.
Purpose of the Study:
- To evaluate the role of biparametric MRI (bpMRI) versus mpMRI in early prostate cancer detection.
- To determine if DCE sequences are essential for all prostate cancer evaluations.
Main Methods:
- Comparison of detection rates between bpMRI (MRI without DCE) and mpMRI for clinically significant prostate cancer.
- Analysis of specific scenarios where adding DCE to bpMRI might be beneficial.
Main Results:
- bpMRI demonstrates comparable detection rates for clinically significant prostate cancer compared to mpMRI.
- MRI screening without DCE is safer, more cost-effective, and reduces gadolinium exposure.
Conclusions:
- bpMRI should be considered the standard for early prostate cancer detection.
- DCE sequences may be reserved for specific indications like post-treatment assessment or persistent suspicion after negative bpMRI.
